SLC11A2 and cancer: The result indicate a concentration-dependent inhibition in STEAP3, DMT1, FPN1, and TFR1 expression upon 6-gingerol treatment, suggesting the capacity of 6-gingerol to suppress iron transport in cancer cells (Figure 5A).